All Stories

  1. Design of a novel oral Retinoic Acid Receptor alpha agonist that is potent and highly selective

    Article • Bioorganic & Medicinal Chemistry, February 2018, Elsevier

    Consultant ALAN DAVID BORTHWICK

  2. A Review of the Discovery, Adrenergic and CNS Activity of Fluparoxan

    Article • Mini-Reviews in Medicinal Chemistry, April 2017, Bentham Science Publishers

    Consultant ALAN DAVID BORTHWICK

  3. 2,5-diketopiperazines in food and beverages: Taste and bioactivity

    Article • Critical Reviews in Food Science and Nutrition, January 2015, Taylor & Francis

    Consultant ALAN DAVID BORTHWICK

  4. Retosiban and Epelsiban: Potent and Selective Orally Available Oxytocin Antagonists

    Article • February 2013, Wiley

    Consultant ALAN DAVID BORTHWICK

  5. 2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products

    Article • Chemical Reviews, May 2012, American Chemical Society (ACS)

    Consultant ALAN DAVID BORTHWICK

  6. Oral Oxytocin Antagonists

    Article • Journal of Medicinal Chemistry, September 2010, American Chemical Society (ACS)

    Consultant ALAN DAVID BORTHWICK